Blueprint Medicines Corp (BPMC) Stock Price, Quote & News

Latest News on BPMC

Jan 12, 2025, 4:00 PM EST - 5 days ago

Blueprint Medicines Provides 2025 Outlook and Highlights Strategy for Continued Growth

Dec 18, 2024, 8:00 AM EST - 4 weeks ago

Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 7, 2024, 12:30 PM EST - 5 weeks ago

Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting

Nov 15, 2024, 5:26 PM EST - 2 months ago

Blueprint Medicines' Growth With AYVAKIT And Next-Gen Oncology Drugs

Nov 14, 2024, 3:18 PM EST - 2 months ago

Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst

Oct 30, 2024, 2:29 PM EDT - 2 months ago

Blueprint Medicines Corporation (BPMC) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 7:00 AM EDT - 2 months ago

Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance

Oct 16, 2024, 8:00 AM EDT - 3 months ago

Blueprint Medicines to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

Sep 11, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Has Launched An Inquiry Into Whether Blueprint Medicines Corporation Violated Securities Laws And Impacted Investors Are Invited To Join

Sep 10, 2024, 11:00 AM EDT - 4 months ago

Blueprint Medicines Corporation Is Being Investigated For Securities Fraud And Stakeholders With Losses Should Contact The Schall Law Firm

Sep 10, 2024, 8:00 AM EDT - 4 months ago

Blueprint Medicines to Present at Upcoming Investor Conferences

$The Schall Law Firm Invites Investors To Join An Inquiry Into Blueprint Medicines Corporation For Possibly Committing Securities Related Infractions$

Sep 9, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Blueprint Medicines Corporation For Possibly Committing Securities Related Infractions

Sep 7, 2024, 11:00 AM EDT - 4 months ago

Blueprint Medicines Corporation May Have Engaged In Securities Fraud And Shareholder Participation In An Investigation Is Encouraged By The Schall Law Firm

Sep 6, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Blueprint Medicines Corporation For Possible Securities Law Violations And Investors Are Urged To Join The Inquiry

Sep 5, 2024, 11:00 AM EDT - 4 months ago

Blueprint Medicines Corporation May Have Defrauded Shareholders And The Schall Law Firm Wants Those With Losses To Reach Out

Sep 4, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Blueprint Medicines Corporation For Potential Securities Law Violations And Investors Are Encouraged To Join

Sep 3, 2024, 11:00 AM EDT - 4 months ago

Blueprint Medicines Corporation May Have Defrauded The Public And The Schall Law Firm Seeks Shareholder Participation In An Inquiry

Sep 2, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Whether Blueprint Medicines Corporation Committed Securities Related Improprieties And Investors Should Reach Out

$Shareholders Can Now Join The Schall Law Firm In Investigating Securities Related Infractions By Blueprint Medicines Corporation$

Sep 1, 2024, 11:00 AM EDT - 4 months ago

Shareholders Can Now Join The Schall Law Firm In Investigating Securities Related Infractions By Blueprint Medicines Corporation

Aug 31, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Blueprint Medicines Corporation's Possible Securities Fraud And Investors Are Invited To Assist

Aug 30, 2024, 11:00 AM EDT - 5 months ago

Blueprint Medicines Corporation May Have Violated Securities Regulations And The Schall Law Firm Seeks Shareholders' Help In The Inquiry

Aug 29, 2024, 11:00 AM EDT - 5 months ago

Investors Are Encouraged To Contact The Schall Law Firm About An Investigation Into Blueprint Medicines Corporation's Securities Related Impropriety

Aug 28, 2024, 11:00 AM EDT - 5 months ago

Blueprint Medicines Corporation May Have Committed Securities Fraud And The Schall Law Firm Seeks Shareholders To Join An Inquiry

Aug 27, 2024, 11:00 AM EDT - 5 months ago

Investors Are Urged To Participate In An Investigation Into Blueprint Medicines Corporation's Potential Securities Law Violations

Aug 26, 2024, 11:00 AM EDT - 5 months ago

Blueprint Medicines Corporation Is Being Looked Into For Possible Securities Fraud And The Schall Law Firm Invites Shareholders To Help

Aug 25, 2024, 11:00 AM EDT - 5 months ago

An Inquiry Has Been Launched Into Blueprint Medicines Corporation For Securities Law Violations And The Schall Law Firm Seeks Investor Involvement

Aug 24, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Is Investigating Blueprint Medicines Corporation For Securities Fraud And Stockholders With Losses Are Invited To Contribute

Aug 23, 2024, 11:00 AM EDT - 5 months ago

Blueprint Medicines Corporation Is Being Looked Into By The Schall Law Firm For Securities Law Violations And Investors Are Urged To Reach Out

Aug 22, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Encourages Stockholders With Losses In Blueprint Medicines Corporation To Participate In A Securities Fraud Investigation

Aug 21, 2024, 11:00 AM EDT - 5 months ago

Investors Are Invited By The Schall Law Firm To Help Investigate Blueprint Medicines Corporation's Potential Securities Law Violations

Aug 20, 2024, 11:00 AM EDT - 5 months ago

Shareholders With Losses In Blueprint Medicines Corporation Are Encouraged To Join The Schall Law Firm In An Investigation Into Potential Securities Law Violations

Aug 19, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Seeks Blueprint Medicines Corporation Investors To Participate In Investigation Into Potential Securities Law Violations

Aug 18, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Wants Blueprint Medicines Corporation Shareholders To Join Investigation Into Potential Securities Law Violations

Aug 17, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Invites Blueprint Medicines Corporation Investors To Join Investigation Into Potential Securities Law Violations

Aug 16, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Asks Blueprint Medicines Corporation Shareholders To Participate In Investigation Into Potential Securities Law Violations

Aug 15, 2024, 7:00 PM EDT - 5 months ago

The Schall Law Firm Invites Investors In Blueprint Medicines Corporation To Join Investigation Into Potential Securities Law Violations

Aug 14, 2024, 10:15 PM EDT - 5 months ago

The Schall Law Firm Informs Investors Of Blueprint Medicines Corporation About Ongoing Investigations Into Potential Securities Law Violations

Aug 13, 2024, 11:15 PM EDT - 5 months ago

The Schall Law Firm Notifies Investors Of Blueprint Medicines Corporation About Ongoing Investigations Into Potential Securities Law Violations

Aug 12, 2024, 8:00 PM EDT - 5 months ago

Investors Of Blueprint Medicines Corporation Are Informed By The Schall Law Firm About Ongoing Investigations Into Possible Securities Law Breaches

Aug 9, 2024, 11:30 PM EDT - 5 months ago

Investors Of Blueprint Medicines Corporation Are Notified By The Schall Law Firm Regarding Ongoing Investigations Into Potential Securities Law Violations

Aug 8, 2024, 8:30 PM EDT - 5 months ago

Investors Of Blueprint Medicines Corporation Are Alerted By The Schall Law Firm About Continuing Probes Into Possible Securities Law Breaches

Aug 7, 2024, 6:00 PM EDT - 5 months ago

Blueprint Medicines Corporation Investors Are Notified By The Schall Law Firm Of Ongoing Investigations Into Potential Securities Law Violations

Aug 6, 2024, 5:45 PM EDT - 5 months ago

Blueprint Medicines Corporation Investors Are Informed By The Schall Law Firm Of Current Investigations Into Potential Securities Law Violations

Aug 1, 2024, 8:40 PM EDT - 6 months ago

Blueprint Medicines Corporation (BPMC) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 7:00 AM EDT - 6 months ago

Blueprint Medicines Reports Second Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance

Jul 26, 2024, 3:30 PM EDT - 6 months ago

Blueprint Medicines Corporation Investors Are Notified By The Schall Law Firm Of Ongoing Investigations Into Possible Securities Law Breaches

Jul 19, 2024, 3:30 PM EDT - 6 months ago

Blueprint Medicines Corporation Investors Are Informed By The Schall Law Firm Of Ongoing Investigations Into Possible Securities Law Breaches

Jul 18, 2024, 5:00 PM EDT - 6 months ago

Market Cap	6.60B
Revenue (ttm)	249.38M
Net Income (ttm)	-506.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-203.30%
Debt to Equity Ratio	1.23

Volume	972,200
Avg Vol	706,524
Day's Range	N/A - N/A
Shares Out	63.53M
Stochastic %K	99%
Beta	0.61
Analysts	Strong Sell
Price Target	$125.26